Document is current
Any future updates will be listed below
-
Authors
Zheng, Hongling
Li, Rui
Ma, Hongli
Cheng, Qinqin
Zhang, Yuxia
Gong, Youwen
Luo, Lei
-
Funding
Funding for this research was provided by:
the Cadre Healthcare Research Programme of Sichuan Province, China (No. 2023-806)
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 19 May 2025
First Online: 5 June 2025
Declarations
:
: This study has been approved by the Ethics Committee of Sichuan Cancer Hospital, the ethics approval number is SCCHEC-02-2023-035. This study was conducted in accordance with the declaration of Helsinki. Each participant was required to complete an electronic informed consent form before proceeding with the questionnaire. The questionnaire could only be filled out after the participant had signed the consent form. Additionally, all information regarding the study participants, including personal details and responses, was kept strictly confidential.
: Not applicable.
: The authors declare no competing interests.
